NFKB1 and prostate carcinoma: Downregulation of PARP14 by siRNA decreases NF-κB activation in gemcitabine-resistant prostate carcinoma cells and consequently promotes apoptosis, suggesting that PARP14 is important for cell viability and required for constitutive NF-κB signaling.